Partial
Partially Aligned
Patient Risk:
Moderate
Summary
The AI-generated list includes multiple statements about torsemide/DEMADEX indications, but the provided label text supports the edema and hypertension indications; however many other claims are not evaluated against the supplied label excerpt, and several statements are not supported by the provided labeling text (e.g., generic/patent/pricing/brand history and multiple mechanistic/administration details).
Category Scores
Accurate Statements
Torsemide has edema-associated indications in congestive heart failure, renal disease, or hepatic disease (DEMADEX label: edema associated with congestive heart failure, renal disease, or hepatic disease).
INDICATIONS AND USAGE: 'DEMADEX is indicated for the treatment of edema associated with congestive heart failure, renal disease, or hepatic disease.'
Torsemide is indicated for treatment of hypertension alone or in combination with other antihypertensive agents (DEMADEX label).
INDICATIONS AND USAGE: 'DEMADEX is indicated for the treatment of hypertension alone or in combination with other antihypertensive agents.'
Use of torsemide has been found to be effective for treatment of edema associated with chronic renal failure (within the provided label excerpt).
INDICATIONS AND USAGE: 'Use of torsemide has been found to be effective for the treatment of edema associated with chronic renal failure.'
Unsupported Statements
Torsemide is available as a generic medication; patent protection has expired; other companies can manufacture and market generic versions; Torsemide has been available as a generic for several years; patent expiries generally allow for generic versions to enter the market; Demadex was first approved in 1993; DrugPatentWatch.com provides information on patent expiries.
These statements are not supported by the supplied prescribing information excerpt (no generic/patent/approval-year/third-party website content present).
Torsemide is a loop diuretic.
The provided label excerpt does not explicitly state 'loop diuretic' in the text shown.
Torsemide helps the body eliminate excess fluid and salt through urine.
The provided excerpt includes torsemide increases urinary excretion of sodium, chloride, and water, but the exact statement 'eliminate excess fluid and salt' is not directly worded in the provided label excerpt.
Torsemide may be used alone and in combination to manage high blood pressure.
While the label supports hypertension alone or in combination, this statement is not tied to the exact label wording in a way that can be verified beyond indication; additionally, the provided label uses 'DEMADEX' and does not explicitly say 'may be used' (it states 'indicated').
Generic torsemide is bioequivalent to the brand-name version; contains the same active ingredient; has the same dosage form; same strength; same route of administration.
Generic product equivalence/pharmaceutical substitution characteristics are not addressed in the supplied prescribing information excerpt.
Inactive ingredients in generic torsemide may differ from those in the brand-name version; differences in inactive ingredients do not affect performance; patients may notice variations in pill appearance; doctors can prescribe generic torsemide; pharmacy can dispense a generic version; insurance plans prefer/require generics; pricing varies and generics are generally less expensive.
These statements are not supported by the provided prescribing information excerpt.
Regulatory bodies like the FDA require generic drugs to meet strict standards for safety, efficacy, and quality.
This regulatory generalization is not supported by the provided prescribing information excerpt.
Torsemide is used to treat edema associated with kidney disease and liver disease (as separate from congestive heart failure/ hepatic disease).
The label excerpt supports 'renal disease' and 'hepatic disease' as edema indications, but the statements are phrased as general 'kidney disease'/'liver disease' rather than the label terms; verification is limited to the provided text.
Contradictions
Low
AI Statement
Torsemide is prescribed to manage high blood pressure (implied in the hypertension statements).
Label Reference
INDICATIONS AND USAGE supports hypertension indication.
Important Omissions
The claim set does not include key contraindications and warnings from the label (e.g., contraindications: hypersensitivity to DEMADEX or sulfonylureas; anuric patients; warnings on hepatic cirrhosis/ascites, ototoxicity, volume/electrolyte depletion, and monitoring of serum potassium/electrolytes).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Indication statements are broadly consistent with the provided label excerpt, but numerous non-label statements (generic/patent/price/biocomparability) are unrelated to prescribing safety, and important label safety content (contraindications/warnings/monitoring) is not addressed in the AI-generated list.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Only the edema and hypertension indications align with the provided label excerpt; many additional claims in the list are not supported by the supplied prescribing information.
Suggested Improvement
Restrict content to what is explicitly stated in the provided prescribing information (or supply additional label text sections for evaluation). Include label-supported contraindications, warnings/precautions, and monitoring requirements when discussing safe prescribing.